Real-World Comparison of Amrubicin and Platinum-Based Doublet Chemotherapy as Second-Line Treatment for Advanced Extrapulmonary Neuroendocrine Carcinoma (ESMO Asia 2026) - Oct 1, 2026 - Abstract #1139eP; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Clinical • Metastases • Real-world • Real-world evidence • Endocrine Cancer • Neuroendocrine Carcinoma • Oncology • Solid Tumor
|
|
Taiki T. Okumura; Takuro T. Noguchi; Shintaro Kanda
|